1. Home
  2. PAR vs MYGN Comparison

PAR vs MYGN Comparison

Compare PAR & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$37.60

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.45

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
MYGN
Founded
1968
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
625.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PAR
MYGN
Price
$37.60
$6.45
Analyst Decision
Strong Buy
Buy
Analyst Count
5
12
Target Price
$64.00
$11.82
AVG Volume (30 Days)
475.9K
910.3K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$440,451,000.00
$825,300,000.00
Revenue This Year
$30.40
$0.08
Revenue Next Year
$12.01
$5.28
P/E Ratio
N/A
N/A
Revenue Growth
39.88
0.21
52 Week Low
$31.65
$3.76
52 Week High
$77.55
$15.47

Technical Indicators

Market Signals
Indicator
PAR
MYGN
Relative Strength Index (RSI) 57.64 39.01
Support Level $36.48 $6.38
Resistance Level $38.50 $6.89
Average True Range (ATR) 1.38 0.29
MACD 0.25 -0.06
Stochastic Oscillator 81.57 5.71

Price Performance

Historical Comparison
PAR
MYGN

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: